Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NEU.AX | ||||
| Company | Neuren Pharmaceuticals Ltd | ||||
| Price Information | |||||
| Exchange | ASX | ||||
| Open | 16.740 | ||||
| High | 17.175 | ||||
| Low | 16.600 | ||||
| Latest | 16.780 | ||||
| Change | +0.040 | ||||
| % Change | +0.24% | ||||
| Volume | 494,962 | ||||
| 20-Day Average Volume | 733,388 | ||||
| Previous Close | 16.740 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 14.650 | ||||
| 20-Day Raw Stochastic | 69.47% | ||||
| 20-Day Relative Strength | 63.65 | ||||
| Weighted Alpha | +3.05 | ||||
| Today's Opinion | 40% Buy | ||||
| Previous Opinion | 40% Buy | ||||
| Last Month's Opinion | 40% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.29% since 07/02/26 | ||||
| Low | 16.080 on 07/07/26 | ||||
| High | 17.200 on 07/03/26 | ||||
| 1-Month | |||||
| %Chg | +24.94% since 06/09/26 | ||||
| Low | 12.070 on 06/26/26 | ||||
| High | 18.850 on 07/01/26 | ||||
| 3-Month | |||||
| %Chg | +33.39% since 04/09/26 | ||||
| Low | 11.680 on 04/28/26 | ||||
| High | 18.850 on 07/01/26 | ||||
| 6-Month | |||||
| %Chg | -12.70% since 01/09/26 | ||||
| Low | 11.000 on 03/23/26 | ||||
| High | 21.040 on 01/14/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 2,122,196 | ||||
| Shares Outstanding, K | 126,774 | ||||
| Annual Sales | 64,634,000 | ||||
| Annual Net Income | 30,436,000 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | 71.94 | ||||